In Situ-Based Gels for Nose to Brain Delivery for the Treatment of Neurological Diseases
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
In Situ-Based Gels for Nose to Brain Delivery for the Treatment of Neurological Diseases
Authors
Keywords
-
Journal
Pharmaceutics
Volume 10, Issue 2, Pages 40
Publisher
MDPI AG
Online
2018-03-31
DOI
10.3390/pharmaceutics10020040
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Brain targeted rivastigmine mucoadhesive thermosensitive In situ gel: Optimization, in vitro evaluation, radiolabeling, in vivo pharmacokinetics and biodistribution
- (2018) Dalia M.N. Abouhussein et al. JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY
- A mucoadhesive, thermoreversible in situ nasal gel of geniposide for neurodegenerative diseases
- (2017) Yingting Wang et al. PLoS One
- Thermoreversible mucoadhesive in situ nasal gel for treatment of Parkinson’s disease
- (2016) Monica Rao et al. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
- Particulate formulations based on chitosan for nose-to-brain delivery of drugs. A review
- (2016) Giovanna Rassu et al. JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY
- Development and Evaluation of a Novel Intranasal Spray for the Delivery of Amantadine
- (2016) Shital Lungare et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Recent trends in pH/thermo-responsive self-assembling hydrogels: from polyions to peptide-based polymeric gelators
- (2016) Christophe Chassenieux et al. Soft Matter
- Brain and other nervous system disorders across the lifespan — global challenges and opportunities
- (2015) Donald Silberberg et al. NATURE
- Brain delivery of intranasalin situgel of nanoparticulated polymeric carriers containing antidepressant drug: behavioral and biochemical assessment
- (2014) Prabhjot Kaur et al. JOURNAL OF DRUG TARGETING
- A changing treatment landscape for multiple sclerosis: challenges and opportunities
- (2014) F. Piehl JOURNAL OF INTERNAL MEDICINE
- FDA-Approved Drugs to Treat Schizophrenia
- (2014) JOURNAL OF PSYCHOSOCIAL NURSING AND MENTAL HEALTH SERVICES
- Stem-Cell Challenges in the Treatment of Alzheimer's Disease: A Long Way from Bench to Bedside
- (2014) Xiaotang Fan et al. MEDICINAL RESEARCH REVIEWS
- Improving and Accelerating Drug Development for Nervous System Disorders
- (2014) Diana E. Pankevich et al. NEURON
- Formulation and Evaluation of Thermosensitive Biogels for Nose to Brain Delivery of Doxepin
- (2014) Anuja Naik et al. Biomed Research International
- Drug Delivery Systems, CNS Protection, and the Blood Brain Barrier
- (2014) Ravi Kant Upadhyay Biomed Research International
- Prevalence and risk factors for neurological disorders in children aged 6 months to 2 years in northern India
- (2013) Rashmi Kumar et al. DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY
- Insights into direct nose to brain delivery: current status and future perspective
- (2013) Deepti Mittal et al. DRUG DELIVERY
- Nasalin-situgels for delivery of rasagiline mesylate: improvement in bioavailability and brain localization
- (2013) P. R. Ravi et al. DRUG DELIVERY
- Development ofin situgel for nasal delivery: design, optimization,in vitroandin vivoevaluation
- (2013) Upendra C. Galgatte et al. DRUG DELIVERY
- Formulation and characterization of intranasal mucoadhesive nanoparticulates and thermo-reversible gel of levodopa for brain delivery
- (2013) Sumit Sharma et al. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
- Induction of Hyperhomocysteinemia Models Vascular Dementia by Induction of Cerebral Microhemorrhages and Neuroinflammation
- (2013) Tiffany L Sudduth et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Enhanced brain targeting of curcumin by intranasal administration of a thermosensitive poloxamer hydrogel
- (2013) Xi Chen et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Development and evaluation of brain targeted intranasal alginate nanoparticles for treatment of depression
- (2013) Shadabul Haque et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Formulations for Intranasal Delivery of Pharmacological Agents to Combat Brain Disease: A New Opportunity to Tackle GBM?
- (2013) Matthias van Woensel et al. Cancers
- Neurological disorders and therapeutics targeted to surmount the blood–brain barrier
- (2012) Jagat Kanwar et al. International Journal of Nanomedicine
- Challenges in drug delivery to the brain: Nature is against us
- (2012) Silke Krol JOURNAL OF CONTROLLED RELEASE
- Nanotechnological advances for the delivery of CNS therapeutics
- (2011) Ho Lun Wong et al. ADVANCED DRUG DELIVERY REVIEWS
- Enhancing CNS Repair in Neurological Disease
- (2011) Xiaohua Xu et al. CNS DRUGS
- Parkinson's Disease Therapeutics: New Developments and Challenges Since the Introduction of Levodopa
- (2011) Yoland Smith et al. NEUROPSYCHOPHARMACOLOGY
- Formulation of intranasal mucoadhesive temperature-mediatedin situgel containing ropinirole and evaluation of brain targeting efficiency in rats
- (2009) Shagufta Khan et al. JOURNAL OF DRUG TARGETING
- Intranasal delivery to the central nervous system: Mechanisms and experimental considerations
- (2009) Shyeilla V. Dhuria et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Challenges in the Search for Drugs to Treat Central Nervous System Disorders
- (2009) S. J. Enna et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Nasal Delivery of High Molecular Weight Drugs
- (2009) Yıldız Ozsoy et al. MOLECULES
- The olfactory vector hypothesis of neurodegenerative disease: Is it viable?
- (2008) Richard L. Doty ANNALS OF NEUROLOGY
- Prevalence of Vitamin D Insufficiency in Patients With Parkinson Disease and Alzheimer Disease
- (2008) Marian L. Evatt et al. ARCHIVES OF NEUROLOGY
- Multiple sclerosis
- (2008) Alastair Compston et al. LANCET
- Levodopa for the Treatment of Parkinson's Disease
- (2008) Peter A. LeWitt NEW ENGLAND JOURNAL OF MEDICINE
- Hydrogels in drug delivery: Progress and challenges
- (2008) Todd R. Hoare et al. POLYMER
- Editorial: Challenges in developing new multiple sclerosis therapies
- (2008) Michael K. Racke Therapeutic Advances in Neurological Disorders
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started